Gene and immune marker study for rheumatoid arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at two markers in the blood of people with rheumatoid arthritis: a gene called GAS5 and a protein called IL-6. It may help doctors understand the disease better and could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with rheumatoid arthritis by a doctor.
- You must meet the standard criteria for RA, which your doctor can confirm.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood markers can help diagnose or monitor rheumatoid arthritis. It may help doctors better understand the disease and guide treatment.
This study looks at a genetic marker (IL-12B) in people with severe psoriasis and psoriatic arthritis who are already on Humira. It may help understand why some people respond better to treatment.
This study is looking for biomarkers (biological clues) in people with newly diagnosed or flaring giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). Participating may help researchers find better ways to diagnose and monitor these conditions.
This study looks at immune system and genetic (inherited) differences in people diagnosed with giant cell arteritis or polymyalgia rheumatica. It aims to improve understanding of why these conditions happen and how they vary between people.
This study follows different groups of people—from those at high risk of developing rheumatoid arthritis to those recently diagnosed—to learn more about the disease. By joining, you help researchers understand who gets RA and why, which may lead to earlier detection and better care.
This study is looking for people with ankylosing spondylitis, rheumatoid arthritis, or lupus to help find biomarkers that may make diagnosis easier. If you have one of these conditions and haven't tried biologic therapies, you may be able to join.
Hear when a new RA - Rheumatoid Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.